The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...

Pneumonia is an infection of the lungs which causes inflammation in the tiny air sacs in the lungs that then fill with fluid ...

A prosecutor told a jury why they should convict seven defendants over the ugly scenes in Ely as defence counsel said the crown was 'desperate' ...

October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.

There are steps physicians can take to prepare their patients with pulmonary issues for the changing of the seasons.

Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...